Literature DB >> 2213563

Nifedipine enhances amoxicillin absorption kinetics and bioavailability in humans.

J F Westphal1, J H Trouvin, A Deslandes, C Carbon.   

Abstract

Intestinal absorption of aminopenicillins in vitro uses the dipeptide carrier system. Recent experiments have reported calcium ion to be a cellular mediator of the regulation of electrolyte transport through the enterocyte membrane, especially the Na/H exchange which is partly responsible for the proton gradient energizing the carrier system. In order to assess the in vivo relevance of these data, we studied, in healthy volunteers, the influence of nifedipine, a calcium channel blocking agent, on the intestinal uptake of amoxicillin, a commonly prescribed and well-absorbed aminopenicillin. Results obtained show that 1) intestinal absorption kinetics of amoxicillin follows a zero-order process, which further substantiates the existence of a saturable carrier-mediated process for this antibiotic in humans and 2) calcium channel blockade significantly enhances both absorption rate (by 70%) and bioavailability of amoxicillin (by 21.4%) without modifying its distribution or elimination. These findings might suggest that nifedipine could enhance amoxicillin intestinal uptake by stimulating its active transport.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213563

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Effects of nifedipine and diltiazem on pharmacokinetics of cefpodoxime following its oral administration.

Authors:  A Deslandes; F Camus; C Lacroix; C Carbon; R Farinotti
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

Review 2.  Vitamin, mineral, and drug absorption following bariatric surgery.

Authors:  Ronald Andari Sawaya; Jane Jaffe; Lindsay Friedenberg; Frank K Friedenberg
Journal:  Curr Drug Metab       Date:  2012-11       Impact factor: 3.731

Review 3.  Intestinal absorption of peptide drugs: advances in our understanding and clinical implications.

Authors:  S M Catnach; P D Fairclough; S M Hammond
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

4.  Low bioavailability of amoxicillin in rats as a consequence of presystemic degradation in the intestine.

Authors:  J Chesa-Jiménez; J E Peris; F Torres-Molina; L Granero
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

5.  PEPT1-mediated cefixime uptake into human intestinal epithelial cells is increased by Ca2+ channel blockers.

Authors:  Uwe Wenzel; Sabine Kuntz; Simone Diestel; Hannelore Daniel
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

6.  Lack of effect of amoxycillin on the absorption of ofloxacin.

Authors:  G Paintaud; G Alván; U Hellgren; I Nilsson-Ehle
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Modeling of the saturable time-constrained amoxicillin absorption in humans.

Authors:  V K Piotrovskij; G Paintaud; G Alván; T Trnovec
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

Review 8.  Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.

Authors:  David E Smith; Benjamin Clémençon; Matthias A Hediger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

9.  Modification of cefixime bioavailability by nifedipine in humans: involvement of the dipeptide carrier system.

Authors:  C Duverne; A Bouten; A Deslandes; J F Westphal; J H Trouvin; R Farinotti; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.